Under Diagnosis and Over Diagnosis of Prostate Cancer-Reference-Cited by-同舟云学术

Under Diagnosis and Over Diagnosis of Prostate Cancer

Published:2007-07 Issue:1 Volume:178 Page:88-92
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Graif Theresa¹,Loeb Stacy²,Roehl Kimberly A.³,Gashti Sara N.¹,Griffin Christopher¹,Yu Xiaoying¹,Catalona William J.¹

Affiliation:

1. Department of Urology, Northwestern Feinberg School of Medicine, Chicago, Illinois

2. Department of Urology, Georgetown University School of Medicine, Washington, D. C.

3. Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Cancer Facts and Figures,2007

2. Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat Database: Mortality-All COD, Public-Use With State, Total U. S. (1969–2003). National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2006. Available at www.seer.cancer.gov. Underlying mortality data provided by National Center for Health Statistics. Available at www.cdc.gov/nchs. Accessed October 18, 2006.

3. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer;Draisma;JNCI,2003

4. What patients should be told before agreeing to a blood test that could change their lives;Talcott;Urology,2003

5. Viewpoint: limiting prostate cancer screening;Hoffman;Ann Intern Med,2006

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer;International Journal of Molecular Sciences;2023-09-28

2. Evaluating the Role of Morphological Parameters in the Prostate Transition Zone in PHI-Based Predictive Models for Detecting Gray Zone Prostate Cancer;Clinical Medicine Insights: Oncology;2023-01

3. Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection;Frontiers in Oncology;2022-04-07

4. The modified prostate health index (PHI) outperforms PHI density in the detection of clinical prostate cancer within the PSA grey zone;International Urology and Nephrology;2022-02-24

5. Development of a tissue discrimination electrode embedded surgical needle using vibro-tactile feedback derived from electric impedance spectroscopy;Medical & Biological Engineering & Computing;2021-10-22